Sunzen Biotech Bhd Stock Net Asset
| 0148 Stock | 0.32 0.00 0.00% |
Sunzen Biotech Bhd fundamentals help investors to digest information that contributes to Sunzen Biotech's financial success or failures. It also enables traders to predict the movement of Sunzen Stock. The fundamental analysis module provides a way to measure Sunzen Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sunzen Biotech stock.
Sunzen |
Sunzen Biotech Bhd Company Net Asset Analysis
Sunzen Biotech's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Sunzen Biotech Net Asset | 148.71 M |
Most of Sunzen Biotech's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sunzen Biotech Bhd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Sunzen Biotech Bhd has a Net Asset of 148.71 M. This is much higher than that of the Consumer Non-Cyclicals sector and significantly higher than that of the Food & Tobacco industry. The net asset for all Malaysia stocks is notably lower than that of the firm.
Sunzen Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sunzen Biotech's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sunzen Biotech could also be used in its relative valuation, which is a method of valuing Sunzen Biotech by comparing valuation metrics of similar companies.Sunzen Biotech is currently under evaluation in net asset category among its peers.
Sunzen Fundamentals
| Return On Equity | 2.91 | |||
| Current Valuation | 128.73 M | |||
| Price To Book | 1.22 X | |||
| Price To Sales | 1.34 X | |||
| Revenue | 90.48 M | |||
| EBITDA | 6.57 M | |||
| Net Income | 3.71 M | |||
| Total Debt | 5.08 M | |||
| Cash Flow From Operations | (16.36 M) | |||
| Market Capitalization | 147.73 M | |||
| Total Asset | 148.71 M | |||
| Z Score | 17.4 | |||
| Net Asset | 148.71 M |
About Sunzen Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sunzen Biotech Bhd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sunzen Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sunzen Biotech Bhd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Sunzen Stock
Sunzen Biotech financial ratios help investors to determine whether Sunzen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sunzen with respect to the benefits of owning Sunzen Biotech security.